This inventor holds 1 USPTO granted patent. Top assignee: Nycomed Imaging as. Active years: 1997.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1997
Title: The Innovations of Erik Agner
Introduction
Erik Agner is a notable inventor based in Oslo, Norway. He has made significant contributions to the field of peptide compounds, particularly in their hemoregulatory activity. His work has led to the development of innovative solutions that have potential applications in various medical fields.
Latest Patents
Erik Agner holds one patent for his invention of double chain peptide compounds that exhibit hemoregulatory activity. This patent represents a significant advancement in the understanding and application of peptide technology.
Career Highlights
Agner is currently employed at Nycomed Imaging AS, where he continues to work on innovative projects. His expertise in peptide compounds has positioned him as a valuable asset to the company and the broader scientific community.
Collaborations
Throughout his career, Erik has collaborated with notable colleagues, including Kjell Undheim and Magne Solbakken. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.
Conclusion
Erik Agner's contributions to the field of peptide compounds highlight his role as an influential inventor. His work continues to inspire advancements in medical technology and research.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile